# Structure
## Chemistry
### Synthesis
$\qquad$$\qquad$$\qquad$• Synthesized in the [[Central Nervous System (CNS)]] (primarily brain) and kidneys
$\qquad$$\qquad$$\qquad$• Synthesized from L-[[Tyrosine]] via [[Tyrosine hydroxylase]] [[klein2018.pdf#page=3&selection=66,0,81,14|klein2018, page 3]]
> the primary metabolic route involves a two-step synthesis in the cytosol. [[Tyrosine hydroxylase]] (the rate-limiting enzyme) converts tyrosine to [[levodopa (L-DOPA)]] using tetrahydrobiopterin, oxygen (O$_2$), and iron (Fe$^{2+}$) as cofactors

$\qquad$$\qquad$$\qquad$• Minor synthesis pathway [[klein2018.pdf#page=3&selection=88,43,92,16|klein2018, page 3]]:
> p-[[Tyramine]] can be converted to [[dopamine]] through [[Cytochrome P450 2D6]] activity in the substantia nigra

$\qquad$$\qquad$$\qquad$• 
### Degradation
$\qquad$$\qquad$$\qquad$• Degraded into [[dopamine]] via [[L-amino acid decarboxylase (DOPA decarboxylase)]]
$\qquad$$\qquad$$\qquad$• [[klein2018.pdf#page=3&selection=81,16,87,23|klein2018, page 3]]
> [[Levodopa (L-DOPA)]] can then be converted to dopamine by aromatic [[l-amino acid decarboxylase (DOPA decarboxylase)]], having [[Pyridoxal Phosphate (B6)]] as a cofactor

$\qquad$$\qquad$$\qquad$• 